Thorne, 35, is sharing the symptoms he experienced before being diagnosed with a stage four brain tumour in the hope of ...

EXCLUSIVE: A young father-of-two who has been told he has just months to live has bravely spoken about the symptoms he suffered before eventually being diagnosed with an aggressive brain tumour ...

DSP-0390 is under clinical development by Sumitomo Pharma and currently in Phase II for Anaplastic Astrocytoma. According to GlobalData, Phase II drugs for Anaplastic Astrocytoma have a 19% phase ...

Everolimus TFOS is a kinase inhibitor indicated in adult and pediatric patients aged one year and older with tuberous ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

CORNELL, Mich. (WLUC) - A Cornell couple says their four-year-old daughter is doing excellent after emergency brain surgery ...

The Neurological and Cognitive Examination Primary Brain Tumor A primary brain tumor can originate from a number of different cells in the brain, such as glial cells (glioma), astrocytes (astrocytoma) ...

Netflix's 'Apple Cider Vinegar' tells the true story of wellness influencer Belle Gibson, who lied about having brain cancer ...

Dr. Waqqas Tai is a cancer doctor who often shares health advice online. He recently revealed what the five most "lethal" ...

Scientists at the facility are seeking and developing new drugs that can target and kill the cancer-causing cells that drive ...

Natco Pharma receives FDA approval for Everolimus tablets, launching generic version of Afinitor Disperz in U.S. market.

Natco Pharma Ltd on Thursday said it has received approval from the US health regulator for its generic version of Everolimus tablets for oral suspension indicated for patients with tuberous sclerosis ...